AdvaMed Presses For More Stringent Enforcement Of Single-Use Devices
This article was originally published in The Gray Sheet
Executive Summary
AdvaMed is asking FDA to crack down on single-use device reprocessors that did not provide the agency with validation data by the January cutoff date
You may also be interested in...
Biopsy Forceps Review Request Prompts Category Change For Nine SUDs
Reprocessed single-use non-electric biopsy forceps will no longer be considered 510(k)-exempt devices, meaning that reprocessors will need to file premarket notification and validation data with FDA by July 30, 2004
EU Anti-Reuse Drive Founders; Pharma Review Strategy Priority Heightened
European Union legislation regulating the reprocessing of single-use medical devices is unlikely, European Commission officials told Eucomed representatives Nov. 22
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.